Altimmune Inc (ALT): Altimmune, Inc. (ALT) Director Purchases...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	71
Posts	11465
Boards Moderated	0
Alias Born	12/25/2009

chmcnfunds

Re: None

Wednesday, 12/06/2017 8:52:55 AM

Wednesday, December 06, 2017 8:52:55 AM

Altimmune, Inc. (ALT) Director Purchases $46,557.90 in Stock

Posted by Mickey Rousseau on Dec 5th, 2017 // No Comments

Altimmune logoAltimmune, Inc. (NYSEARCA:ALT) Director Derace L. Schaffer bought 26,010 shares of the firm’s stock in a transaction that occurred on Tuesday, December 5th. The shares were purchased at an average cost of $1.79 per share, for a total transaction of $46,557.90. Following the completion of the transaction, the director now owns 300,373 shares of the company’s stock, valued at $537,667.67. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

Separately, Piper Jaffray Companies assumed coverage on Altimmune in a report on Monday, October 9th. They set an “overweight” rating and a $6.00 price objective on the stock.

Insider Buying and Selling by Quarter for Altimmune (NYSEARCA:ALT)
_____________________________________________
https://www.dispatchtribunal.com/2017/12/05/altimmune-inc-alt-director-purchases-46557-90-in-stock.html

ALT
_____________________________________